Compare EIKN & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EIKN | EOI |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.6M | 805.7M |
| IPO Year | N/A | 2004 |
| Metric | EIKN | EOI |
|---|---|---|
| Price | $10.53 | $18.61 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $25.60 | N/A |
| AVG Volume (30 Days) | ★ 301.9K | 68.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.76 | $15.50 |
| 52 Week High | $16.50 | $21.58 |
| Indicator | EIKN | EOI |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 27.65 |
| Support Level | N/A | N/A |
| Resistance Level | $16.34 | $20.90 |
| Average True Range (ATR) | 1.27 | 0.27 |
| MACD | -0.21 | -0.09 |
| Stochastic Oscillator | 6.15 | 0.00 |
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation. The company's sector allocation includes: Information Technology, Communication Services, Financials, Consumer Discretionary, Healthcare, Industries, Consumer Staples, Energy, Real Estate, and Materials.